✦ LIBER ✦

PMS47 The Health and Economic Consequences of Delay in Starting Disease-Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis

✍ Scribed by S. Van doornum; L. Roberts; M.D. Reed; D. Liew

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The early use of disease-modifying antir

✍ Edward S. Mongan 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 2 views

Termination of disease-modifying antirhe

✍ Ilona Ujfalussy; Éva Koó; Magdolna Seszták; Péter Gergely 📂 Article 📅 2003 🏛 Springer-Verlag 🌐 German ⚖ 104 KB

Etanercept in combination with conventio

✍ Yoshinobu Koyama; Hirokazu Shiraishi; Toshiyuki Ohta; Ayumi Uchino 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 350 KB

Role of disease-modifying antirheumatic

✍ John R. Ward 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 907 KB

The use of combinations of disease-modif

✍ Harold E. Paulus 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 773 KB

Efficacy, Tolerability and Cost Effectiv

✍ Dr Michael T. Nurmohamed, Ben A. C. Dijkmans 📂 Article 📅 2005 🏛 Springer International Publishing AG 🌐 English ⚖ 389 KB